209 related articles for article (PubMed ID: 22552290)
21. NUMB suppression by miR-9-5P enhances CD44
Wang X; Cai J; Zhao L; Zhang D; Xu G; Hu J; Zhang T; Jin M
Sci Rep; 2021 May; 11(1):11210. PubMed ID: 34045601
[TBL] [Abstract][Full Text] [Related]
22. Expression of microRNA-328 Functions as a Biomarker for Recurrence of Early Gastric Cancer (EGC) After Endoscopic Submucosal Dissection (ESD) by Modulating CD44.
Xue HG; Yang AH; Sun XG; Lu YY; Tian ZB
Med Sci Monit; 2016 Dec; 22():4779-4785. PubMed ID: 27923017
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.
Li JZ; Wang ZL; Xu WH; Li Q; Gao L; Wang ZM
Cancer Invest; 2016; 34(4):181-8. PubMed ID: 27031291
[TBL] [Abstract][Full Text] [Related]
24. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of miR-137 in patients with hepatocellular carcinoma.
Sakabe T; Azumi J; Umekita Y; Toriguchi K; Hatano E; Hirooka Y; Shiota G
Liver Int; 2017 Feb; 37(2):271-279. PubMed ID: 27473646
[TBL] [Abstract][Full Text] [Related]
26. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
27. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
Huang Q; Gumireddy K; Schrier M; le Sage C; Nagel R; Nair S; Egan DA; Li A; Huang G; Klein-Szanto AJ; Gimotty PA; Katsaros D; Coukos G; Zhang L; Puré E; Agami R
Nat Cell Biol; 2008 Feb; 10(2):202-10. PubMed ID: 18193036
[TBL] [Abstract][Full Text] [Related]
28. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
Ju SY; Chiou SH; Su Y
Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
[TBL] [Abstract][Full Text] [Related]
29. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.
Park J; Kim SY; Kim HJ; Kim KM; Choi EY; Kang MS
Oncotarget; 2016 May; 7(19):28670-83. PubMed ID: 27107424
[TBL] [Abstract][Full Text] [Related]
30. MIR-150 promotes prostate cancer stem cell development via suppressing p27Kip1.
Liu DZ; Zhang HY; Long XL; Zou SL; Zhang XY; Han GY; Cui ZG
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4344-52. PubMed ID: 26636522
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
[TBL] [Abstract][Full Text] [Related]
32. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells.
Lin B; Chen T; Zhang Q; Lu X; Zheng Z; Ding J; Liu J; Yang Z; Geng L; Wu L; Zhou L; Zheng S
Oncotarget; 2016 Nov; 7(47):77495-77507. PubMed ID: 27769048
[TBL] [Abstract][Full Text] [Related]
33. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
35. MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression.
Li JZ; Li J; Wang HQ; Li X; Wen B; Wang YJ
Biochem Biophys Res Commun; 2017 Jan; 482(4):1381-1386. PubMed ID: 27956179
[TBL] [Abstract][Full Text] [Related]
36. Significantly altered expression of miR-511-3p and its target AKT3 has negative prognostic value in human prostate cancer.
Zhang F; Wu Z
Biochimie; 2017 Sep; 140():66-72. PubMed ID: 28624527
[TBL] [Abstract][Full Text] [Related]
37. Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer.
Bucay N; Sekhon K; Majid S; Yamamura S; Shahryari V; Tabatabai ZL; Greene K; Tanaka Y; Dahiya R; Deng G; Saini S
Oncotarget; 2016 Oct; 7(43):70388-70403. PubMed ID: 27611943
[TBL] [Abstract][Full Text] [Related]
38. Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.
Klarmann GJ; Hurt EM; Mathews LA; Zhang X; Duhagon MA; Mistree T; Thomas SB; Farrar WL
Clin Exp Metastasis; 2009; 26(5):433-46. PubMed ID: 19221883
[TBL] [Abstract][Full Text] [Related]
39. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
[TBL] [Abstract][Full Text] [Related]
40. miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells.
Huang S; Guo W; Tang Y; Ren D; Zou X; Peng X
Oncol Rep; 2012 Nov; 28(5):1831-7. PubMed ID: 22948942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
